Skip to main content

Alopecia clinical trials at UCSF

3 in progress, 0 open to eligible people

Showing trials for
  • Long-Term PF-06651600 for the Treatment of Alopecia Areata

    Sorry, in progress, not accepting new patients

    This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia areata. Eligible patients from the prior studies B7931005 (NCT02974868) and B7981015 (NCT03732807) will have an opportunity to enroll as well as patients who have not previously participated in either of these studies. The study is open-label and all patients entering the study will receive active study drug. A sub-study of approximately 60 adult patients who are participating in the B7981032 study will be conducted at select sites in the US, Australia and Canada. The sub-study will evaluate the immune response to tetanus and meningococcal vaccines in patients who have received a minimum of 6 months of 50 mg PF-06651600.

    San Francisco, California and other locations

  • Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)

    Sorry, not yet accepting patients

    The purpose of this post-market, prospective study is to assess the ability of AMMA to prevent hair loss in women receiving chemotherapy (CT) for early-stage breast cancer.

    San Francisco, California

  • Alopecia Areata Registry

    Sorry, in progress, not accepting new patients

    Alopecia areata is the loss of hair in patches that can proceed to loss of all hair (alopecia totalis or universalis). The purpose of the registry is to collect patient information and blood samples from people with alopecia areata.

    San Francisco, California and other locations

Our lead scientists for Alopecia research studies include .

Last updated: